AutoGenomics Launches Familial Mediterranean Fever Panel, Plans FDA Submission | GenomeWeb

By Justin Petrone

AutoGenomics this month introduced an assay panel for mutations implicated in the development of familial Mediterranean fever.

The new assay, which is currently available for research use only, runs on the firm's array-based Infiniti system and provides multiplexed determination of 13 genetic variants common to more than 10 afflicted ethnicities of Mediterranean origin.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.